Thomson Reuters sells healthcare unit to Veritas

NEW YORK Mon Apr 23, 2012 10:49pm IST

Related Topics

Stocks

   

NEW YORK (Reuters) - Thomson Reuters Corp (TRI.TO) (TRI.N) said on Monday it is selling its Healthcare business to private equity firm Veritas Capital for $1.25 billion in cash.

The sale is part of the professional news and information provider's plan to shed non-core businesses to concentrate on faster growth areas like financial risk and compliance.

"We expect management will use the proceeds to invest or make acquisitions in growing segments of the business," UBS analyst Phillip Huang wrote in a note.

"This is consistent with CEO Jim Smith's playbook ... and we expect management will use this same strategy to try to accelerate growth in the Financial & Risk segment."

Thomson Reuters said last June that it intended to sell its Healthcare unit, which provides data, analytics and other services to improve efficiency to hospitals, government agencies and healthcare professionals. The sale was temporarily suspended in December due to challenging economic conditions, the company said at the time.

In 2010, Healthcare pulled in approximately $450 million in revenue with an operating margin of about 19 percent.

Thomson Reuters is trying to accelerate growth in the wake of the financial crisis, during which customers in banking and finance laid off tens of thousands of employees and cut costs.

The sale of the Healthcare unit, subject to regulatory approval, is expected to close in the next few months.

Veritas Capital has obtained debt financing commitments for the transaction, which is not subject to any financing condition.

Morgan Stanley (MS.N) and Allen & Company are acting as financial advisors to Thomson Reuters on the proposed divestiture. Covington & Burling LLP is acting as legal counsel.

Thomson Reuters' U.S. shares were down 1.5 percent at $28.45 on the New York Stock Exchange amid a broader market sell off. On the Toronto exchange shares were down 1.3 percent at C$28.27.

(Reporting by Soyoung Kim, Editing by Tiffany Wu and Alden Bentley)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Earnings Season

Earnings Season

Reliance Q4 sales rise, refining margin narrows.  Read 

Innovative Solution

Innovative Solution

Turning smog into jewels - a Dutch designer's solution to Beijing's pollution.  Video 

Insider Trading

Insider Trading

Rajaratnam's brother loses bid to dismiss insider trading charges.  Full Article 

Literary Giant Dies

Literary Giant Dies

Mourning and memories in Gabriel Garcia Marquez's languid hometown.  Full Article 

S&P on India

S&P on India

S&P: India's ratings to depend on next govt econ, fiscal policies.  Full Article 

Ambitious Aim

Ambitious Aim

In green car race, Toyota adds muscle with fuel-cell launch.  Full Article 

Bond Market

Bond Market

A star abroad, RBI boss riles bond traders at home  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage